A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer
Clinical trial NCT07735377 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07735377
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2026-08-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.